Last reviewed · How we verify
Periurethral application of estradiol cream
Periurethral application of estradiol cream is a Small molecule drug developed by Stephanie Wang Zuo. It is currently in Phase 2 development.
At a glance
| Generic name | Periurethral application of estradiol cream |
|---|---|
| Sponsor | Stephanie Wang Zuo |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Periurethral application of estradiol cream CI brief — competitive landscape report
- Periurethral application of estradiol cream updates RSS · CI watch RSS
- Stephanie Wang Zuo portfolio CI
Frequently asked questions about Periurethral application of estradiol cream
What is Periurethral application of estradiol cream?
Periurethral application of estradiol cream is a Small molecule drug developed by Stephanie Wang Zuo.
Who makes Periurethral application of estradiol cream?
Periurethral application of estradiol cream is developed by Stephanie Wang Zuo (see full Stephanie Wang Zuo pipeline at /company/stephanie-wang-zuo).
What development phase is Periurethral application of estradiol cream in?
Periurethral application of estradiol cream is in Phase 2.